Growth Metrics

Health Catalyst (HCAT) Shares Outstanding (Diluted Average) (2019 - 2026)

Health Catalyst filings provide 8 years of Shares Outstanding (Diluted Average) readings, the most recent being $72.6 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 5.89% to $72.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $72.6 million, a 5.89% increase, with the full-year FY2025 number at $69.9 million, up 16.14% from a year prior.
  • Shares Outstanding (Diluted Average) hit $72.6 million in Q1 2026 for Health Catalyst, up from $69.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $72.6 million in Q1 2026 to a low of $53.2 million in Q1 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $58.6 million (2024), compared with a mean of $60.5 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 21.3% in 2022 and later rose 3.77% in 2023.
  • Health Catalyst's Shares Outstanding (Diluted Average) stood at $54.1 million in 2022, then grew by 4.32% to $56.4 million in 2023, then increased by 6.68% to $60.2 million in 2024, then grew by 16.14% to $69.9 million in 2025, then increased by 3.86% to $72.6 million in 2026.
  • The last three reported values for Shares Outstanding (Diluted Average) were $72.6 million (Q1 2026), $69.9 million (Q4 2025), and $69.5 million (Q3 2025) per Business Quant data.